Intermed Labs and Vandalia Health advance real-time cardiac communication technology to improve heart attack response

Intermed Labs, a medtech venture studio specializing in healthcare innovation commercialization, announced that it has advanced a new physician-led technology developed in collaboration with Marc Dotson, DO, of Vandalia Health, to its final prototype stage, marking a significant milestone toward commercialization.

Designed to improve communication during suspected heart attacks, the technology enables emergency medical services (EMS), emergency departments, and on-call cardiologists to securely share critical patient information before the patient arrives at the hospital. The platform delivers field electrocardiograms (ECGs), ambulance location, estimated arrival time, and clinical updates through a real-time mobile workflow, giving care teams greater visibility during one of healthcare's most time-sensitive emergencies.

Heart attacks require rapid clinical decision-making, yet hospitals often receive fragmented or delayed information from the field. These communication gaps can slow specialist review, delay cardiac catheterization lab preparation, and reduce valuable treatment time when every minute can impact patient outcomes.

By connecting first responders and hospital teams before arrival, the technology is designed to support faster clinical awareness, earlier care coordination, and improved operational readiness.

"As physicians, we experience firsthand where communication breaks down during emergency care," Dr. Dotson said. "The goal of this technology is to provide specialists with the information they need while the patient is still en route to the hospital, allowing teams to prepare sooner and coordinate care more effectively. We believe improving communication has the potential to make a meaningful difference for both providers and patients."

Intermed Labs has partnered with Dr. Dotson and Vandalia Health throughout the innovation process, providing commercialization strategy, product development guidance, prototype design, intellectual property support, and market validation to transform the clinical concept into a scalable healthcare technology. The project has now reached what is expected to be its final prototype phase before commercialization.

"The best healthcare innovations begin with clinicians who understand the challenges of patient care because they live them every day," said Ashok Aggarwal, Co-Founder of Intermed Labs. "Our role is to help transform those ideas into real-world solutions by providing the structure, expertise, and commercialization pathway needed to move from concept to market. This project with Dr. Dotson is another example of how physician-led innovation can create technologies with the potential to improve care delivery across the healthcare system."

Intermed Labs works with physicians, researchers, health systems, and entrepreneurs to identify unmet clinical needs and guide innovations from idea through commercialization. Through its venture studio model, the company provides strategic support across product validation, intellectual property, prototype development, regulatory planning, business strategy, and commercialization, helping accelerate the adoption of technologies that improve patient care and healthcare operations.